Phenotypic and genotypic detection of carbapenemase production among gram negative bacteria isolated from hospital acquired infections

References

1. 1.↵
   1. Haque M,
   2. Sartelli M,
   3. McKimm J,
   4. Abu Bakar M.

   Health care-associated infections - an overview. Infect Drug Resist 2018; 11: 2321–2333.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. He Q,
   2. Wang W,
   3. Zhu S,
   4. Wang M,
   5. Kang Y,
   6. Zhang R, et al.

   The epidemiology and clinical outcomes of ventilator-associated events among 20,769 mechanically ventilated patients at intensive care units: an observational study. Crit Care 2021; 25: 44.

   OpenUrl
3. 3.↵
   1. Paveenkittiporn W,
   2. Lyman M,
   3. Biedron C,
   4. Chea N,
   5. Bunthi C,
   6. Kolwaite A, et al.

   Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018. Antimicrob Resist Infect Control 2021; 10: 88.

   OpenUrl
4. 4.↵
   1. Al-Ouqaili MTS,
   2. Al-Taei SA,
   3. Al-Najjar A.

   Molecular detection of medically important carbapenemases genes expressed by Metallo-β-lactamase producer isolates of Pseudomonas aeruginosa and Klebsiella pneumonia. Asian Journal of Pharmaceutics 2018; 12: S991–S1001.

   OpenUrl
5. 5.↵
   1. Eatemadi A,
   2. Al Risi E,
   3. Kasliwal AK,
   4. Al Záabi A,
   5. Moradzadegan H,
   6. Aslani Z.

   A proposed evidence-based local guideline for definition of multidrug-resistant (MDR), extensively drug-resistant (XDR) and pan drug-resistant (PDR) bacteria by the Microbiology Laboratory. IJCSRR 2021; 4: 146–153.

   OpenUrl
6. 6.↵
   1. Rea-Neto A,
   2. Youssef NC,
   3. Tuche F,
   4. Brunkhorst F,
   5. Ranieri VM,
   6. Reinhart K, et al.

   Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 2008; 12: R56.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Breijyeh Z,
   2. Jubeh B,
   3. Karaman R.

   Resistance of Gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules 2020; 25: 1340.

   OpenUrlCrossRef
8. 8.↵
   1. Shugart A,
   2. Mahon G,
   3. Huang JY,
   4. Karlsson M,
   5. Valley A,
   6. Lasure M, et al.

   Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018. JAC Antimicrob Resist 2021; 3: dlab137.

   OpenUrl
9. 9.
   1. Sękowska A,
   2. Bogiel T,
   3. Kaczmarek A.

   Evaluation of the usefulness of selected methods for the detection of carbapenemases in Klebsiella strains. J Med Microbiol 2020; 69: 792–796.

   OpenUrl
10. 10.↵
    World Health Organization. WHO global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. [Updated 2017; 2021 Aug 16]. Available from: https://www.aidsdatahub.org/resource/who-global-priority-list-antibiotic-resistant-bacteria
11. 11.↵
    1. Bouganim R,
    2. Dykman L,
    3. Fakeh O,
    4. Motro Y,
    5. Oren R,
    6. Daniel C, et al.

    The clinical and molecular epidemiology of noncarbapenemase-producing carbapenem-resistant Enterobacteriaceae: A case-case-control matched analysis. Open Forum Infect Dis 2020; 7: ofaa299.

    OpenUrl
12. 12.↵
    1. Gajdács M,
    2. Ábrók M,
    3. Lázár A,
    4. Jánvári L,
    5. Tóth Á,
    6. Terhes G, et al.

    Detection of VIM, NDM and OXA-48 producing carbapenem resistant Enterobacterales among clinical isolates in Southern Hungary. Acta Microbiol Immunol Hung 2020; 67: 209–215.

    OpenUrl
13. 13.↵
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 20th informational supplement, Doc. M100ED29-2019. [Updated 2019; 2019 Jan]. Available from: https://clsi.org/
14. 14.↵
    1. Cury AP,
    2. Girardello R,
    3. Duarte AJDS,
    4. Rossi F.

    KPC-producing Enterobacterales with uncommon carbapenem susceptibility profile in Vitek 2 system. Int J Infect Dis 2020; 93: 118–120.

    OpenUrl
15. 15.↵
    1. Walthall K,
    2. Anderson K,
    3. Reese N,
    4. Lonsway D,
    5. Rasheed JK,
    6. Karlsson M.

    Evaluation of the RAPIDEC CARBA NP, conventional CarbaNP, and the modified carbapenem inactivation method (mCIM) tests for phenotypic detection of carbapenemase-producing organisms. AJCP 2018; 150: S123–S124.

    OpenUrl
16. 16.↵
    1. Suryavanshi KT,
    2. Lahiri KK.

    Assessment of RapidecCarba NP test, as screening test to detect carbapenemase, specially metallo-β-lactamase producing Gram negative bacteria at tertiary care centre. IJHSR 2018; 8: 56–61.

    OpenUrl
17. 17.↵
    1. Al-Ouqaili MTS,
    2. Khalaf EA,
    3. Al-Kubaisy SH.

    DNA sequence analysis of BlaVEB gene encoding multi-drug resistant and extended-spectrum β-lactamases producer isolates of Enterobacteriaceae and Pseudomonas aeruginosa. The Open Microbiology Journal 2020; 14: 40–47.

    OpenUrl
18. 18.↵
    1. Haji SH,
    2. Aka STH,
    3. Ali FA.

    Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli. PLoS One 2021; 16: e0259005.

    OpenUrl
19. 19.↵
    1. Mohammed MU,
    2. Manisha DR,
    3. Nagamani K.

    Clinical, phenotypic and genotypic profile of carbapenem resistant Gram negative infections in intensive care units. Indian J Microbiol Res 2021; 8: 28–34.

    OpenUrl
20. 20.↵
    1. Diwakar J,
    2. Verma RK,
    3. Singh DP,
    4. Singh A,
    5. Kumari S.

    Phenotypic detection of carbapenem resistance in Gram-negative bacilli from various clinical specimens of a tertiary care hospital in Western Uttar Pradesh. Int J Res Med Sci 2017; 5: 3511–3514.

    OpenUrl
21. 21.↵
    1. Garg A,
    2. Garg J,
    3. Kumar S,
    4. Bhattacharya A,
    5. Agarwal S,
    6. Upadhyay GC.

    Molecular epidemiology and therapeutic options of carbapenem-resistant Gram-negative bacteria. Indian J Med Res 2019; 149: 285–289.

    OpenUrlCrossRef
22. 22.↵
    1. Al-Ouqaili MTS,
    2. Jal’oot AS,
    3. Badawy AS.

    Identification of an OprD and blaIMP Gene-mediated carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa among patients with wound infections in Iraq. Asian Journal of Pharmaceutics 2018; 12: S959.

    OpenUrl
23. 23.↵
    1. Naim H,
    2. Rizvi M,
    3. Gupta R,
    4. Azam M,
    5. Taneja N,
    6. Shukla I, et al.

    Drug resistance and molecular epidemiology of carbapenem resistant Gram-negative bacilli isolates. J Glob Infect Dis 2018; 10: 133–139.

    OpenUrl
24. 24.↵
    1. Otter JA,
    2. Burgess P,
    3. Davies F,
    4. Mookerjee S,
    5. Singleton J,
    6. Gilchrist M, et al.

    Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. Clin Microbiol Infect 2017; 23: 188–196.

    OpenUrl
25. 25.↵
    1. Mohanam L,
    2. Menon T.

    Coexistence of metallo-beta-lactamase-encoding genes in Pseudomonas aeruginosa. Indian J Med Res 2017; 146: S46–S52.

    OpenUrl
26. 26.↵
    1. Ellappan K,
    2. Belgode Narasimha H,
    3. Kumar S.

    Coexistence of multidrug resistance mechanisms and virulence genes in carbapenem-resistant Pseudomonas aeruginosa strains from a tertiary care hospital in South India. J Glob Antimicrob Resist 2018; 12: 37–43.

    OpenUrl
27. 27.↵
    1. Vatansever C,
    2. Menekse S,
    3. Dogan O,
    4. Gucer LS,
    5. Ozer B,
    6. Ergonul O, et al.

    Co-existence of OXA-48 and NDM-1 in colistin resistant Pseudomonas aeruginosa ST235. Emerg Microbes Infect 2020; 9: 152–154.

    OpenUrl
28. 28.↵
    1. Esther J,
    2. Edwin D

    , Uma. Prevalence of carbapenem resistant non-fermenting Gram-negative bacterial infection and identification of carbapenemase producing NFGNB isolates by simple phenotypic tests. J Clin Diagn Res 2017; 11: DC10-DC13.

    OpenUrl
29. 29.↵
    1. Pan F,
    2. Tian D,
    3. Wang B,
    4. Zhao W,
    5. Qin H,
    6. Zhang T, et al.

    Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai. BMC Infect Dis 2019; 19: 678.

    OpenUrlCrossRef